Compare APP & WELL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | APP | WELL |
|---|---|---|
| Founded | 2012 | 1970 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Real Estate Investment Trusts |
| Sector | Technology | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 141.6B | 142.5B |
| IPO Year | 2021 | 1994 |
| Metric | APP | WELL |
|---|---|---|
| Price | $458.69 | $208.00 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 17 | 11 |
| Target Price | ★ $703.71 | $227.09 |
| AVG Volume (30 Days) | ★ 5.4M | 2.6M |
| Earning Date | 05-12-2026 | 05-11-2026 |
| Dividend Yield | N/A | ★ 1.44% |
| EPS Growth | ★ 115.23 | N/A |
| EPS | ★ 9.75 | 1.39 |
| Revenue | $5,480,717,000.00 | ★ $10,838,034,000.00 |
| Revenue This Year | $47.55 | $28.66 |
| Revenue Next Year | $29.08 | $6.03 |
| P/E Ratio | ★ $46.10 | $148.32 |
| Revenue Growth | 16.38 | ★ 35.63 |
| 52 Week Low | $200.50 | $130.29 |
| 52 Week High | $745.61 | $216.43 |
| Indicator | APP | WELL |
|---|---|---|
| Relative Strength Index (RSI) | 47.99 | 59.20 |
| Support Level | $345.95 | $182.12 |
| Resistance Level | $473.69 | $209.05 |
| Average True Range (ATR) | 25.69 | 3.80 |
| MACD | 7.04 | -0.82 |
| Stochastic Oscillator | 56.98 | 73.70 |
AppLovin is a vertically integrated advertising technology company that acts as a demand-side platform for advertisers, a supply-side platform for publishers, and an exchange facilitating transactions between the two. About 80% of AppLovin's revenue comes from the DSP, AppDiscovery, while the remainder comes from the SSP, Max. AppLovin's primary tool for future growth is AXON 2, which is an ad optimizer operating within the DSP that allows advertisers to place ads according to specified return thresholds.
Welltower owns a diversified healthcare portfolio of 2,900 in-place properties spread across the senior housing, medical office, and skilled nursing/postacute care sectors. The portfolio includes over 900 properties in Canada and the United Kingdom as the company looks for additional investment opportunities in countries with mature healthcare systems that operate similarly to that of the United States.